CoChat

“Ependymal‐in” Gradient of Thalamic Damage in Progressive Multiple Sclerosis

Open access
Magliozzi, Roberta, Fadda, Giulia, Brown, Robert A., Bar‐Or, Amit, Howell, Owain W., Hametner, Simon, Marastoni, Damiano, Poli, Alberto, Nicholas, Richard, Calabrese, Massimiliano, Monaco, Salvatore, Reynolds, Richard · 2022 · Annals of Neurology
Cited by 68

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Leptomeningeal and perivenular infiltrates are important contributors to cortical grey matter damage and disease progression in multiple sclerosis (MS). Whereas perivenular inflammation induces vasculocentric lesions, leptomeningeal involvement follows a subpial “surface‐in” gradient. To determine whether similar gradient of damage occurs in deep grey matter nuclei, we examined the dorsomedial thalamic nuclei and cerebrospinal fluid (CSF) samples from 41 postmortem secondary progressive MS cases compared with 5 non‐neurological controls and 12 controls with other neurological diseases. CSF/ependyma‐oriented gradient of reduction in NeuN+ neuron density was present in MS thalamic lesions compared to controls, greatest (26%) in subventricular locations at the ependyma/CSF boundary and least with increasing distance (12% at 10 mm). Concomitant graded reduction in SMI31+ axon density was observed, greatest (38%) at 2 mm from the ependyma/CSF boundary and least at 10 mm (13%). Conversely, gradient of major histocompatibility complex (MHC)‐II+ microglia density increased by over 50% at 2 mm at the ependyma/CSF boundary and only by 15% at 10 mm and this gradient inversely correlated with the neuronal (R = −0.91, p < 0.0001) and axonal (R = −0.79, p < 0.0001) thalamic changes. Observed gradients were also detected in normal‐appearing thalamus and were associated with rapid/severe disease progression; presence of leptomeningeal tertiary lymphoid‐like structures; large subependymal infiltrates, enriched in CD20+ B cells and occasionally containing CXCL13+ CD35+ follicular dendritic cells; and high CSF protein expression of a complex pattern of soluble inflammatory/neurodegeneration factors, including chitinase‐3‐like‐1, TNFR1, parvalbumin, neurofilament‐light‐chains and TNF. Substantial “ependymal‐in” gradient of pathological cell alterations, accompanied by presence of intrathecal inflammation, compartmentalized either in subependymal lymphoid perivascular infiltrates or in CSF, may play a key role in MS progression. Summary for Social Media: Imaging and neuropathological evidences demonstrated the unique feature of “surface‐in” gradient of damage in multiple sclerosis (MS) since early pediatric stages, often associated with more severe brain atrophy and disease progression. In particular, increased inflammation in the cerebral meninges has been shown to be strictly associated with an MS‐specific gradient of neuronal, astrocyte, and oligodendrocyte loss accompanied by microglial activation in subpial cortical layers, which is not directly related to demyelination. To determine whether a similar gradient of damage occurs in deep grey matter nuclei, we examined the potential neuronal and microglia alterations in the dorsomedial thalamic nuclei from postmortem secondary progressive MS cases in combination with detailed neuropathological characterization of the inflammatory features and protein profiling of paired CSF samples. We observed a substantial “subependymal‐in” gradient of neuro‐axonal loss and microglia activation in active thalamic lesions of progressive MS cases, in particular in the presence of increased leptomeningeal and cerebrospinal fluid (CSF) inflammation. This altered graded pathology was found associated with more severe and rapid progressive MS and increased inflammatory degree either in large perivascular subependymal infiltrates, enriched in B cells, or within the paired CSF, in particular with elevated levels of a complex pattern of soluble inflammatory and neurodegeneration factors, including chitinase 3‐like‐1, TNFR1, parvalbumin, neurofilament light‐chains and TNF. These data support a key role for chronic, intrathecally compartmentalized inflammation in specific disease endophenotypes. CSF biomarkers, together with advance imaging tools, may therefore help to improve not only the disease diagnosis but also the early identification of specific MS subgroups that would benefit of more personalized treatments. ANN NEUROL 2022;92:670–685

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.26448

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 68

Metadata

Authors
Magliozzi, R., Fadda, G., Brown, R. A., Bar‐Or, A., Howell, O. W., Hametner, S., Marastoni, D., Poli, A., Nicholas, R., Calabrese, M., Monaco, S., & Reynolds, R.
Venue
Annals of Neurology
Publisher
Wiley
Published
2022-07-30
Volume
92
Issue
4
Pages
670-685
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W4283456266
Cited by
68
References
11
FWCI
7.47
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: “Ependymal‐in” Gradient of Thalamic Damage in Progressive Multiple Sclerosis. https://app.cochat.ai/papers/10.1002/ana.26448
The paper
Magliozzi, R., Fadda, G., Brown, R. A., Bar‐Or, A., Howell, O. W., Hametner, S., Marastoni, D., Poli, A., Nicholas, R., Calabrese, M., Monaco, S., & Reynolds, R. (2022). “Ependymal‐in” Gradient of Thalamic Damage in Progressive Multiple Sclerosis. Annals of Neurology. https://doi.org/10.1002/ana.26448

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.